Commonwealth Equity Services’s Regulus Therapeutics RGLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,700	Closed	-$18K	–	4270
2024 Q4	$18K	Buy	11,700 +200	+2%	+$307	﹤0.01%	4050
2024 Q3	$18K	Sell	11,500 -6,500	-36%	-$10.8K	﹤0.01%	4005
2024 Q2	$32K	Hold	18,000	–	–	﹤0.01%	3932
2024 Q1	$52K	Buy	18,000 +500	+3%	+$815	﹤0.01%	3887
2023 Q4	$22K	Hold	17,500	–	–	﹤0.01%	3813
2023 Q3	$24K	Hold	17,500	–	–	﹤0.01%	3720
2023 Q2	$26K	Hold	17,500	–	–	﹤0.01%	3729
2023 Q1	$14	Hold	17,500	–	–	﹤0.01%	3699
2022 Q4	$23K	Sell	17,500 -16,000	-48%	-$25.2K	﹤0.01%	3589
2022 Q3	$56K	Buy	33,500 +11,500	+52%	+$20.7K	﹤0.01%	3471
2022 Q2	$45K	Buy	22,000 +8,900	+68%	+$21.6K	﹤0.01%	3502
2022 Q1	$39K	Buy	13,100 +1,200	+10%	+$3.12K	﹤0.01%	3608
2021 Q4	$37K	Buy	11,900 +800	+7%	+$3.56K	﹤0.01%	3561
2021 Q3	$76K	Buy	11,100 +3,100	+39%	+$22.7K	﹤0.01%	3455
2021 Q2	$65K	Buy	8,000 +6,000	+300%	+$67K	﹤0.01%	3442
2021 Q1	$31K	Buy	+2,000	New	+$29.6K	﹤0.01%	3360